Profile
Presently, Kaz works for a global tech giant to head up its Asian corporate development endeavors, including M&A, JV, CVC investments etc. Prior to this role, at Houlihan Lokey Corporation, Kaz played central roles in originating and executing M&A, investments, licensing and IPO deals in life sciences and healthcare, including biopharma, med device and digital health. Prior to Houlihan Lokey Corporation, he was the Head of Asia Pacific at Deloitte’s Corporate Finance practice. Prior experiences include the ED of the investment banking division of Mitsubishi UFJ Morgan Stanley Securities, involved in a number of large-scale transactions (M&A/IPO, etc.), venture capital investment and M&A support in the U.S., research and study at a think tank, and PMI, production/development, SI, etc. at a leading manufacturer. He has a MS in Bioinformatics from the University of Maryland, an MBA from the University of Pennsylvania, and is a CFA. Co-authored three books and published many papers and lectures
Strengths
For startup companies, support for financing, licensing, and divestment; for large companies/funds, support for identifying acquisition and investment opportunities and establishing CVC (investment strategy, systems and organizations, marketing, etc.)
Main areas of consultation
M&A / IPO / Financing
Other areas for consultation
IP, Business Development&Licensing
